Pure Global

Therapy Dual-8 Ablation Catheter - Cardiac radio-frequency ablation system catheter - ARTG 482926

Access comprehensive regulatory information for Therapy Dual-8 Ablation Catheter - Cardiac radio-frequency ablation system catheter in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 482926 and sponsored by Abbott Medical Australia Pty Ltd, manufactured by Abbott Medical in United States of America. The device registration started on March 18, 2025.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 482926
Class III
Therapy Dual-8 Ablation Catheter - Cardiac radio-frequency ablation system catheter
ARTG ID: 482926
Good Name: Abbott Medical Australia Pty Ltd - Therapy Dual-8 Ablation Catheter - Cardiac radio-frequency ablation system catheter
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Therapy Dual 8 Ablation Catheter is indicated for intracardiac recording of complex conduction disturbances and the delivery of radio-frequency energy for therapeutic purposes. As well as, for the treatment of AV nodal reentrant tachycardia, ablation of accessory pathways, and the creation of complete AV block in atrial arrhythmias.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
482926
Start Date
March 18, 2025
Effective Date
March 18, 2025
Manufacturer
Country
United States of America
Address
2375 Morse Avenue, Irvine, California, 92614